XML 91 R76.htm IDEA: XBRL DOCUMENT v3.22.4
14. Segment Reporting (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting Information [Line Items]      
Number Of Products And Services 12,000    
Net sales $ 2,802,200 $ 2,922,500 $ 2,545,600
Interest expense 38,114 1,551 21,861
Depreciation and amortization 137,300 137,600 138,600
Segment profit 482,616 500,336 421,326
Total assets 13,501,666 17,799,393  
Payments to Acquire Property, Plant, and Equipment 112,782 133,746 108,564
Life Science [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,347,200 1,400,800 1,231,800
Depreciation and amortization 57,900 54,800 50,500
Segment profit 266,800 319,700 282,600
Total assets 269,900 207,700 220,600
Clinical Diagnostics [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,451,000 1,515,900 1,305,200
Depreciation and amortization 79,400 82,800 88,100
Segment profit 217,700 181,800 138,300
Total assets 448,800 363,500 401,200
All Other Segments [Member]      
Segment Reporting Information [Line Items]      
Net sales 4,000 5,800 8,600
Depreciation and amortization 0 0 0
Segment profit (1,900) (1,200) 400
Total assets $ 600 $ 1,000 $ 500